Aspira Sale Purchase Of Stock vs Net Income Analysis
AWH Stock | USD 0.75 0.02 2.74% |
Aspira Womens financial indicator trend analysis is way more than just evaluating Aspira Womens Health prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aspira Womens Health is a good investment. Please check the relationship between Aspira Womens Sale Purchase Of Stock and its Net Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
Sale Purchase Of Stock vs Net Income
Sale Purchase Of Stock vs Net Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aspira Womens Health Sale Purchase Of Stock account and Net Income. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Aspira Womens' Sale Purchase Of Stock and Net Income is -0.29. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Net Income in the same time period over historical financial statements of Aspira Womens Health, assuming nothing else is changed. The correlation between historical values of Aspira Womens' Sale Purchase Of Stock and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Aspira Womens Health are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Sale Purchase Of Stock i.e., Aspira Womens' Sale Purchase Of Stock and Net Income go up and down completely randomly.
Correlation Coefficient | -0.29 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Sale Purchase Of Stock
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Aspira Womens Health financial statement analysis. It represents the amount of money remaining after all of Aspira Womens Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most indicators from Aspira Womens' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aspira Womens Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. The current Selling General Administrative is estimated to decrease to about 11.5 M. The current Issuance Of Capital Stock is estimated to decrease to about 191.9 K
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 35.7M | 37.1M | 24.1M | 20.9M | Cost Of Revenue | 3.8M | 3.9M | 3.9M | 3.4M |
Aspira Womens fundamental ratios Correlations
Click cells to compare fundamentals
Aspira Womens Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aspira Womens fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 13.8M | 19.6M | 41.1M | 17.4M | 6.3M | 5.9M | |
Total Stockholder Equity | 8.7M | 9.7M | 30.2M | 6.7M | (2.4M) | (2.2M) | |
Net Debt | (10.4M) | (11.5M) | (33.1M) | (9.5M) | 255K | 267.8K | |
Cash | 11.7M | 16.6M | 37.2M | 13.3M | 2.6M | 2.5M | |
Other Assets | 65K | 419.0 | 264K | 414K | 1.0 | 0.95 | |
Cash And Short Term Investments | 11.7M | 16.6M | 37.2M | 13.3M | 2.6M | 2.5M | |
Common Stock Shares Outstanding | 5.8M | 6.7M | 7.4M | 7.8M | 9.2M | 9.7M | |
Liabilities And Stockholders Equity | 13.8M | 19.6M | 41.1M | 17.4M | 6.3M | 5.9M | |
Other Stockholder Equity | 430.8M | 449.7M | 501.8M | 505.5M | 515.9M | 326.2M | |
Total Liab | 5.1M | 9.9M | 10.9M | 10.6M | 8.6M | 14.1M | |
Total Current Assets | 13.4M | 18.6M | 40.0M | 16.3M | 5.3M | 5.0M | |
Short Long Term Debt Total | 1.3M | 5.1M | 4.1M | 3.8M | 2.9M | 2.7M | |
Other Current Liab | 39K | 4.0M | 5.3M | 3.7M | 2.9M | 2.7M | |
Total Current Liabilities | 4.0M | 6.4M | 7.8M | 5.8M | 5.1M | 6.0M | |
Property Plant And Equipment Net | 353K | 989K | 810K | 650K | 693K | 658.4K | |
Retained Earnings | (422.2M) | (440.1M) | (471.7M) | (498.9M) | (518.3M) | (492.4M) | |
Accounts Payable | 950K | 1.2M | 1.1M | 1.5M | 1.3M | 1.5M | |
Non Current Assets Total | 418K | 1.0M | 1.1M | 1.1M | 982K | 932.9K | |
Non Currrent Assets Other | 65K | 13K | 264K | 414K | 289K | 274.6K | |
Net Receivables | 924K | 865K | 1.0M | 1.2M | 1.5M | 2.0M | |
Common Stock Total Equity | 60K | 75K | 97K | 105K | 120.8K | 126.8K | |
Non Current Liabilities Total | 1.1M | 3.5M | 3.1M | 4.9M | 3.5M | 3.3M | |
Inventory | 25K | 30K | 174K | 316K | 227K | 215.7K | |
Other Current Assets | 758K | 2.2M | 1.6M | 1.4M | 2.0M | 2.1M | |
Property Plant And Equipment Gross | 353K | 989K | 3.6M | 650K | 585K | 555.8K | |
Short Term Debt | 193K | 1.3M | 1.0M | 1.2M | 995K | 945.3K | |
Common Stock | 97K | 105K | 112K | 125K | 11K | 10.5K | |
Long Term Debt | 1.1M | 3.1M | 2.7M | 2.3M | 2.1M | 2.0M | |
Short Long Term Debt | 193K | 1.6M | 980K | 1.2M | 1.1M | 997.8K | |
Net Tangible Assets | 8.7M | 9.7M | 30.2M | 6.7M | 6.1M | 5.8M | |
Long Term Debt Total | 1.5M | 1.3M | 1.1M | 3.1M | 3.5M | 3.7M | |
Capital Surpluse | 399.4M | 414.0M | 430.8M | 449.7M | 517.1M | 453.1M | |
Property Plant Equipment | 353K | 989K | 810K | 650K | 585K | 800.6K |
Currently Active Assets on Macroaxis
When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.801 | Quarterly Revenue Growth (0.03) | Return On Assets (1.86) | Return On Equity (7.23) |
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.